Congressional Hearing on Abortion Pills Raises Questions on Gender and Pregnancy

WASHINGTON — During a recent congressional hearing focused on abortion pills, Dr. Nisha Verma, a Democratic witness and senior advisor for Physicians for Reproductive Health, faced repeated inquiries about whether men can become pregnant. Throughout the session, she carefully avoided giving a direct answer.

When questioned by Senator Ashley Moody (R-Fla.), Verma initially sidestepped the inquiry. Later, Senator Josh Hawley (R-Missouri) pressed her again, only to receive a vague response. Verma explained her hesitation, stating, “I wasn’t really sure where the conversation was headed. I mean, I care for patients with various identities, especially women.”

Hawley pointed out that the aim of his question was to underscore biological facts, reminding her that evidence and science should guide the discussion. He suggested they test that assertion.

“I deal with people who don’t identify as women,” Verma later stated, branding the yes-or-no questions as political maneuvers. She accused Hawley of oversimplifying a complex issue, labeling his questions as “polarizing.”

In response, Hawley emphasized, “It’s women who get pregnant, not men.” His frustration was apparent as he expressed that without agreement on such a fundamental point, the credibility of Verma’s scientific claims could be in question.

“I thought everything was over,” Verma remarked, suggesting the tension in the room was palpable.

The incident gained traction online, particularly during the Senate Health, Education, Labor, and Pensions (HELP) Committee hearing that touched on the safety of abortion pills.

This hearing took place amid ongoing debates over abortion and a backdrop of conflicts between pro-life advocates and the Trump administration regarding the pill’s approval. Last October, the FDA authorized a generic version of mifepristone, a drug utilized to terminate pregnancies.

Pro-life groups continue to call for more extensive research into the safety of mifepristone, even as pro-choice supporters argue that multiple studies have validated its safety.

Statistically speaking, almost two-thirds of abortions in the U.S. are performed with medications like mifepristone and misoprostol, according to the Guttmacher Institute. Mifepristone has been in use in the U.S. since 2000 and is also prescribed for treating Cushing’s syndrome.

Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty McCulley have committed to investigating mifepristone’s safety.

Moreover, Hawley has been actively involved in the legal debates surrounding abortion pills, alongside his wife Erin, who is also at the forefront of this contentious issue.